Vimarsana
Biggest News Aggregation in the World

Johnc Lantis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnc Lantis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnc Lantis Today - Breaking & Trending Today

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences - Vimarsana News

MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences

Oral presentations include additional comparative data between EscharEx® and SANTYL®, and new analyses show strong correlation between wound bed preparation and wound healing Analyses validate the...

Dr. John C. Lantis named Editor-in-Chief of HMP Global's WOUNDS journal; Dr. Terry Treadwell transitions to Editor-in-Chief Emeritus - Vimarsana News

Dr. John C. Lantis named Editor-in-Chief of HMP Global's WOUNDS journal; Dr. Terry Treadwell transitions to Editor-in-Chief Emeritus

Malvern, PA (PRWEB) May 30, 2023 -- HMP Global’s industry-leading journal WOUNDS today announced that Dr. John C. Lantis II is the new Editor-in-Chief, with

Source: prweb.com
Arch Therapeutics Announces Formation of Medical Advisory - Vimarsana News

Arch Therapeutics Announces Formation of Medical Advisory

Wound care professionals across multiple specialties to support strategic alignment of patient, payor, and provider goals...

MediWound Announces Formation of Strategic Advisory Board - Vimarsana News

MediWound Announces Formation of Strategic Advisory Board

25.10.2022 - Esteemed group of industry leaders to contribute expertise and experience to MediWound’s strategic and operational activitiesYAVNE, Israel, Oct. 25, 2022 (GLOBE NEWSWIRE) - MediWound Ltd. (NASDAQ: MDWD), a fully integrated biopharmaceutical ... Seite 1

MediWound's EscharEx Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022 - Vimarsana News

MediWound's EscharEx Featured in Oral and Poster Presentations at the Symposium on Advanced Wound Care (SAWC) Fall 2022

18.10.2022 - EscharEx’s promising results from the completed Phase 2 trials were highlightedYAVNE, Israel, Oct. 18, 2022 (GLOBE NEWSWIRE) - MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation biotherapeutic ... Seite 1